This report contains market size and forecasts of Anti-Hypertensive Drugs in global, including the following market information:
- Global Anti-Hypertensive Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Anti-Hypertensive Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-Hypertensive Drugs companies in 2021 (%)
The global Anti-Hypertensive Drugs market was valued at 40890 million in 2021 and is projected to reach US$ 48250 million by 2028, at a CAGR of 2.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diuretics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Hypertensive Drugs include Novartis, Pfizer, Johnson & Johnson, Sanofi, Lupin, Ranbaxy Laboratories, Merck, AstraZeneca and Daiichi Sankyo Company Limited and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Hypertensive Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Hypertensive Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, by Type, 2021 (%)
- Diuretics
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Angiotensin Receptor Blockers (ARBs)
- Calcium Channel Blockers
- Beta Blockers
- Alpha Blockers
- Vasodilators
- Renin Inhibitors
Global Anti-Hypertensive Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anti-Hypertensive Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-Hypertensive Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-Hypertensive Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Anti-Hypertensive Drugs revenues share in global market, 2021 (%)
- Key companies Anti-Hypertensive Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Anti-Hypertensive Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis
- Pfizer
- Johnson & Johnson
- Sanofi
- Lupin
- Ranbaxy Laboratories
- Merck
- AstraZeneca
- Daiichi Sankyo Company Limited
- Takeda Pharmaceutical
